Royalty Pharma PLC
F:RPD
Wall Street
Price Targets
RPD Price Targets Summary
Royalty Pharma PLC
According to Wall Street analysts, the average 1-year price target for
RPD
is 43.22 EUR
with a low forecast of 37.49 EUR and a high forecast of 52.84 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is RPD's stock price target?
Price Target
43.22
EUR
According to Wall Street analysts, the average 1-year price target for
RPD
is 43.22 EUR
with a low forecast of 37.49 EUR and a high forecast of 52.84 EUR.
What is Royalty Pharma PLC's Revenue forecast?
Projected CAGR
16%
For the last 7 years the
compound annual growth rate for
Royalty Pharma PLC's revenue is
4%.
The projected
CAGR
for the next 3 years is
16%.
What is Royalty Pharma PLC's Operating Income forecast?
Projected CAGR
25%
For the last 7 years the
compound annual growth rate for
Royalty Pharma PLC's operating income is
2%.
The projected
CAGR
for the next 3 years is
25%.
What is Royalty Pharma PLC's Net Income forecast?
Projected CAGR
67%
For the last 7 years the
compound annual growth rate for
Royalty Pharma PLC's net income is
-8%.
The projected
CAGR
for the next 3 years is
67%.
